You have 9 free searches left this month | for more free features.

City

Atlanta (1)

Chicago (1)

Houston (1)

Iowa City (1)

Madison (1)

Nashville (1)

Saint Paul (1)

San Antonio (1)

Santa Monica (1)

Condition

CRC (1)

KRAS Gene Mutation (1)

NSCLC (1)

Solid Tumors (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Calithera Biosciences, Inc (1)

Collaborator

Intervention

palbociclib oral capsule or tablet [ibrance] (1)

telaglenestat (cb-839) (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

Telaglenestat

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Solid Tumors, NSCLC, CRC Trial in United States (Telaglenestat (CB-839), Palbociclib Oral Capsule or Tablet [Ibrance])

Completed

Solid Tumors
+3 more

Telaglenestat (CB-839)
Palbociclib Oral Capsule or Tablet [Ibrance]

Santa Monica, California
+9 more

Sep 14, 2022